rs281860615

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 6P and 2B. PM2PP3_StrongBP6_Moderate

The NM_000517.6(HBA2):​c.273G>C​(p.Lys91Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K91M) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 24)

Consequence

HBA2
NM_000517.6 missense

Scores

3
6
7

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.455
Variant links:
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.965
BP6
Variant 16-173302-G-C is Benign according to our data. Variant chr16-173302-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 2428705.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HBA2NM_000517.6 linkc.273G>C p.Lys91Asn missense_variant Exon 2 of 3 ENST00000251595.11 NP_000508.1 P69905D1MGQ2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HBA2ENST00000251595.11 linkc.273G>C p.Lys91Asn missense_variant Exon 2 of 3 1 NM_000517.6 ENSP00000251595.6 P69905

Frequencies

GnomAD3 genomes
Cov.:
24
GnomAD4 exome
Cov.:
27
GnomAD4 genome
Cov.:
24

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 30, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Uncertain
-0.020
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Benign
0.018
.;T
Eigen
Benign
-0.51
Eigen_PC
Benign
-0.50
FATHMM_MKL
Benign
0.47
N
M_CAP
Pathogenic
0.44
D
MetaRNN
Pathogenic
0.96
D;D
MetaSVM
Uncertain
0.16
D
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-1.5
N;N
REVEL
Uncertain
0.52
Sift
Pathogenic
0.0
D;D
Sift4G
Benign
0.31
T;T
Vest4
0.59
MutPred
0.97
Loss of ubiquitination at K91 (P = 0.0167);.;
MVP
1.0
MPC
1.5
ClinPred
0.85
D
GERP RS
2.0
gMVP
0.98

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr16-223301; API